With so many weight loss medications on the market, it’s easy to feel overwhelmed by the options. From brand-name heavy ...
Medication fills for Zepbound have increased by more than 300% since the start of the year. The average out-of-pocket cost for patients was $230 per fill — the highest of any medication included in ...
Prescriptions for weight-loss drugs surged in 2024 and were much more popular in some states, particularly those in the South ...
Zepbound outperformed Wegovy for weight loss in a new clinical trial funded by Eli Lilly & Co., Zepbound's maker.
Despite this escalating demand for popular GLP-1 drugs, the prices for some of these products are actually dropping. Dr.
Eli Lilly just shared some new information. That data suggests it has an advantage against Novo Nordisk in a key market.
The biotech disclosed Friday plans to terminate a Phase 2 study testing azelaprag with tirzepatide for weight loss following ...
People are reporting that their weight-loss medication helps them steer clear of drugs and alcohol. Studies are promising, ...
Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...
The European Commission granted unconditional approval to Novo Holdings’ $16.5 billion takeover of Catalent, a decision both ...
The top China executive of US pharmaceutical company Eli Lilly and Co said on Wednesday that the company aims to make its ...
Eli Lilly said it would invest $3 billion to expand a recently acquired manufacturing facility to meet growing demand for its diabetes and weight-loss medicines. The drugmaker said the Kenosha County, ...